Ruo Xu

1.8k total citations
42 papers, 1.3k citations indexed

About

Ruo Xu is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Ruo Xu has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Ruo Xu's work include Enzyme Catalysis and Immobilization (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Plant-Microbe Interactions and Immunity (4 papers). Ruo Xu is often cited by papers focused on Enzyme Catalysis and Immobilization (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Plant-Microbe Interactions and Immunity (4 papers). Ruo Xu collaborates with scholars based in United States, China and United Kingdom. Ruo Xu's co-authors include Dan Nettleton, Ronald Breslow, Tomoaki Hishida, Ying Gu, Juan Carlos Izpisúa Belmonte, Concepción Rodrı́guez Esteban, John Marlett, Mo Li, Arturo Diaz and Keiichiro Suzuki and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Ruo Xu

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruo Xu United States 18 708 286 207 91 77 42 1.3k
Jean‐François Hernandez France 24 1.0k 1.5× 224 0.8× 237 1.1× 347 3.8× 38 0.5× 69 1.8k
Luís Maurício T. R. Lima Brazil 27 1.3k 1.9× 75 0.3× 74 0.4× 48 0.5× 37 0.5× 102 2.0k
Kenton L. Longenecker United States 19 664 0.9× 109 0.4× 44 0.2× 36 0.4× 21 0.3× 32 1.1k
Tadayasu Ohkubo Japan 29 1.5k 2.1× 155 0.5× 55 0.3× 136 1.5× 59 0.8× 104 2.1k
Vanessa Gurtu United States 7 743 1.0× 81 0.3× 67 0.3× 134 1.5× 17 0.2× 7 1.1k
Jianye Zang China 25 1.8k 2.6× 111 0.4× 225 1.1× 90 1.0× 28 0.4× 76 2.3k
Kishore V. L. Parsa India 25 829 1.2× 733 2.6× 21 0.1× 266 2.9× 32 0.4× 77 1.8k
Yeon Gyu Yu South Korea 20 790 1.1× 81 0.3× 109 0.5× 67 0.7× 61 0.8× 73 1.2k
A. Sami Sarıbaş United States 19 509 0.7× 26 0.1× 147 0.7× 42 0.5× 99 1.3× 35 1.1k

Countries citing papers authored by Ruo Xu

Since Specialization
Citations

This map shows the geographic impact of Ruo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruo Xu more than expected).

Fields of papers citing papers by Ruo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruo Xu. The network helps show where Ruo Xu may publish in the future.

Co-authorship network of co-authors of Ruo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruo Xu. A scholar is included among the top collaborators of Ruo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruo Xu. Ruo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doamekpor, S.K., et al.. (2023). A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations. Acta Crystallographica Section F Structural Biology Communications. 79(4). 95–104. 3 indexed citations
2.
Zhao, Zhiqiang, Dmitri Pissarnitski, Hubert Josien, et al.. (2016). Substituted 4-morpholine N -arylsulfonamides as γ-secretase inhibitors. European Journal of Medicinal Chemistry. 124. 36–48. 12 indexed citations
3.
Xu, Ruo, et al.. (2016). Effects of Removal of Chemical Components on Moisture Adsorption by Wood. BioResources. 11(2). 16 indexed citations
4.
Liao, Hsin‐Kai, Ying Gu, Arturo Diaz, et al.. (2015). Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nature Communications. 6(1). 6413–6413. 271 indexed citations
5.
Zhao, Zhiqiang, Dmitri Pissarnitski, Hubert Josien, et al.. (2015). Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors. Journal of Medicinal Chemistry. 58(22). 8806–8817. 19 indexed citations
6.
Pliego, Clara, Daniela Nowara, Ruo Xu, et al.. (2013). Host-Induced Gene Silencing in Barley Powdery Mildew Reveals a Class of Ribonuclease-Like Effectors. Molecular Plant-Microbe Interactions. 26(6). 633–642. 146 indexed citations
7.
Xu, Ruo, et al.. (2012). Proteomics-based, multivariate random forest method for prediction of protein separation behavior during cation-exchange chromatography. Journal of Chromatography A. 1249. 103–114. 11 indexed citations
8.
Burnett, Duane A., Theodros Asberom, Wen‐Lian Wu, et al.. (2010). Tetracyclic sulfones as potent γ-secretase inhibitors: Synthesis and structure–activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 20(12). 3645–3648. 6 indexed citations
9.
Li, Hongmei, Ruo Xu, David Cole, et al.. (2010). Design, synthesis, and structure–activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(22). 6606–6609. 12 indexed citations
10.
Huang, Yina H., Juris A. Grasis, Andrew T. Miller, et al.. (2007). Positive Regulation of Itk PH Domain Function by Soluble IP 4. Science. 316(5826). 886–889. 71 indexed citations
11.
Li, Hongmei, Theodros Asberom, Thomas Bara, et al.. (2007). Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6290–6294. 16 indexed citations
12.
Xu, Ruo, Shengjian Li, Mark D. McBriar, et al.. (2006). Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry. 14(10). 3285–3299. 22 indexed citations
13.
McBriar, Mark D., Henry Guzik, Sherry Shapiro, et al.. (2006). Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: Impacting hERG liability via aryl modifications. Bioorganic & Medicinal Chemistry Letters. 16(16). 4262–4265. 11 indexed citations
14.
Lou, Wen‐Yong, Ruo Xu, & Min‐Hua Zong. (2005). Hydroxynitrile Lyase Catalysis in Ionic Liquid-containing Systems. Biotechnology Letters. 27(18). 1387–1390. 10 indexed citations
15.
Zong, Min‐Hua, et al.. (2005). Synthesis of (R)-2-trimethylsilyl-2-hydroxyl-ethylcyanide catalyzed with (R)-oxynitrilase from loquat seed meal. Biotechnology Letters. 27(2). 79–82. 5 indexed citations
16.
Xu, Ruo. (2004). Recent Progress on Biocatalysis and Biotransformations in Ionic Liquids. 中国化学工程学报(英文版). 4 indexed citations
17.
Xu, Ruo, Min‐Hua Zong, Yuying Liu, et al.. (2004). Enzymatic enantioselective transcyanation of silicon-containing aliphatic ketone with (S)-hydroxynitrile lyase from Manihot esculenta. Applied Microbiology and Biotechnology. 66(1). 27–33. 10 indexed citations
18.
Xu, Ruo, et al.. (2003). Genotyping of Hepatitis C Virus in Hebei Province. Virologica Sinica. 18(6). 611–613. 1 indexed citations
19.
Xu, Ruo. (2002). On Portfolio Problem Contained Fuzzy Profit Rate. Mohu xitong yu shuxue.
20.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(21). 3149–3152. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026